Premium
Should neurologists wait and see or see and treat RRMS?
Author(s) -
Bates David,
Isaacs John
Publication year - 2009
Publication title -
progress in neurology and psychiatry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.19
H-Index - 12
eISSN - 1931-227X
pISSN - 1367-7543
DOI - 10.1002/pnp.135
Subject(s) - medicine , rheumatoid arthritis , multiple sclerosis , disease , intensive care medicine , relapsing remitting , physical therapy , physical medicine and rehabilitation , psychiatry
Early and aggressive treatment of rheumatoid arthritis (RA) is now regarded as best practice to limit irreversible joint damage. However, in the case of relapsing remitting multiple sclerosis (RRMS), current guidelines recommend that disease modifying therapy should only be initiated in patients with evidence of actively progressing disease. Here, the authors present the key findings of the Programme Identifying and Observing Novel Therapy Adoption in Chronic Diseases (PIONEER) study to examine the reasons for these different management approaches. Copyright © 2009 Wiley Interface Ltd